ABMD -- Is Its Stock Price A Worthy Investment? Learn More. ABMD Stock Summary. Abiomed Inc's stock had its IPO on July 30, 1987, making it an older stock than 91.47% of US equities in our set. The ratio of debt to operating expenses for Abiomed Inc is higher than it is for about just 0.34% of US stocks. Abiomed, Inc. (ABMD) Stock Analysis & News | Seeking Alpha Get breaking news and analysis on Abiomed, Inc. (ABMD) stock, price quote and chart, trading and investing tools. Abiomed Should Be Trading At Double Its Current Valuation. ABMD - Abiomed Stock Price History - Barchart.com When negative, the current price is that much lower than the highest price reported for the period. When positive, the current price is that much higher than the highest price from that period. New Lows. This widget shows the number of times this symbol reached a new low price for specific periods, from the past 5-Days to the past 20-Years. Abiomed Inc., ABMD Quick Chart - (NAS) ABMD, Abiomed Inc ...
View today's stock price, news and analysis for Abiomed Inc. (ABMD). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and …
1 Year % Chg -46.38. Market Cap 6.9B. Shares Outstanding 45.1M. Beta 0.61. Dividend (Yield) -. Div Amount -. Ex Div Date -. Earnings Date 2020-04-30. View the latest Abiomed Inc. (ABMD) stock price, news, historical charts, analyst ratings and financial information from WSJ. Abiomed Inc stocks price quote with latest real-time prices, charts, financials, latest news, Abiomed Inc (ABMD) Earnings Estimates - Current Qtr 03/31/20. According to analysts' consensus price target of $224.80, ABIOMED has a potential upside of 49.6% from its current price of $150.26. Amount of Analyst Coverage. ABMD Abiomed, Inc. daily Stock Chart Employees, 1371, Current Ratio, 5.00, Sales Q/Q, 10.50%, Oper. ABMD: Which Stock Is the Better Value Option? Abiomed stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news. of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. ABIOMED market cap as of April 03,
Get ABIOMED Inc (ABMD:NASDAQ) real-time stock quotes, news and financial information from CNBC.
View today's stock price, news and analysis for Abiomed Inc. (ABMD). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … ABMD: ABIOMED, Inc. - Price & Consenus Chart - Zacks.com ABMD: ABIOMED, Inc. - Price and Consensus Chart. Get the latest Price and Consensus Chart for ABIOMED, Inc. from Zacks Investment Research displays the … ABMD: Dividend Date & History for ABIOMED, Inc. Gain insights on investing and current trends from the leading fund managers and industry experts. ABIOMED, Inc. ABMD Dividend Yield & Stock Price History Download Historical Dividend Data for ABMD in .XLS Dividend Payout History. ABMD Abiomed Should Be Trading At Double Its Current Valuation ...
ABMD, Abiomed Inc - Stock quote performance, technical chart analysis, Medtech CEO Promises To 'Correct The Course' As Shares Dive On Sales Lag.
ABMD - Abiomed Inc. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. Historical and current end-of-day data provided by FACTSET. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange
ABMD Abiomed, Inc. daily Stock Chart Employees, 1371, Current Ratio, 5.00, Sales Q/Q, 10.50%, Oper. ABMD: Which Stock Is the Better Value Option?
Check ABMD stock rating before trading ABIOMED, Inc. ABIOMED, Inc.'s stock rating is based on fundamental analysis. Don't miss ABMD stock next rating changes ABIOMED Price to Book Ratio 2006-2019 | ABMD | MacroTrends Historical price to book ratio values for ABIOMED (ABMD) over the last 10 years. The current price to book ratio for ABIOMED as of March 31, 2020 is 6.25 . Breaking News: ABMD latest news. - The Fly A study of 21,848 non-emergent, high-risk patients who underwent percutaneous coronary intervention, or PCI, with percutaneous ventricular assist devices, or PVADs, including Impella, demonstrates the PVAD patients had a lower rate of mortality and complications than patients who underwent PCI with intra-aortic balloon pumps, or IABPs.